EORTC Cancer Research Fund
Help drive critical clinical cancer research and give hope to patients and loved ones.
The European Organisation for Research and Treatment of Cancer (EORTC) is an
academic clinical research organisation, which unites cancer research
experts across the globe to define better treatments for patients to prolong survival and improve quality of life. Both international and multidisciplinary, EORTC’s network comprises of over 3,800 members involved in cancer treatment and research in more than 1,000 institutions across 58 countries. Conducting translational research, and phase 2 and 3 trials, EORTC offers an integrated approach to therapeutic strategies and quality of life. EORTC Headquarters, a unique international clinical research infrastructure, are based in Brussels, Belgium, from where its various activities are coordinated and run.
EORTC pushes the boundaries of treatment options to improve patient care. Spanning all cancer types and treatments as well as working across borders, we are currently engaged in 150 trials at distinct stages of development including several practice-changing trials.
The EORTC Cancer Research Fund (ECRF) is the funding arm of this scientific organization with a mission to promote, encourage and support research on the treatment of cancer under the auspices of the EORTC. Unlike commercially driven research, ECRF supports academic clinical cancer research that prioritises therapeutic progress for patients—not profit.
Fundraisers
Official fundraiser
Help EORTC Drive Life-Saving Radiotherapy Forward
Stand with Cancer Patients for World Radiotherapy Awareness Day – September 7! On September 7, we mark the first-ever World Radiotherapy Awareness Day (WRAD), a global moment to spotlight one of the most powerful tools in cancer care: radiation therapy. Why September 7? It’s the anniversary of the first patient ever treated with a linear accelerator in 1953. Today, radiotherapy helps half of all cancer patients live longer and better—but access is still unequal and more research is urgently needed to make treatments safer, more precise, and available to everyone who needs them. EORTC: Driving Radiotherapy Forward Your support fuels EORTC’s groundbreaking research, from real-world data platforms like E2-RADIatE to clinical trials tackling rare and complex cancers. Thanks to donors like you, we are helping: Extend survival amongst patients living with prostate cancer with combined radiation and hormone therapy; Prevent brain metastases in lung cancer patients; Reduce relapse in early breast cancer with targeted radiation boosts. When you give to EORTC, you’re not just funding research—you’re standing with every family navigating cancer. Every gift brings us closer to a future where no patient is left behind. Take Action Today Donate to accelerate life-saving radiotherapy research. Thank you.
- Raised
- $0
- Next milestone
- $100
